Home
Eric Karas, Chief Commercial Officer: ARS Pharmaceuticals SPRY Sell · Filed 06/12
Trade details
- Type
- Insider sale
- Amount
- $250,000
- Shares · price
- 25,000 sh · $10.00 a share
- Held after
- 12,176 sh
- Trade date
- 26/06/12
- Filed
- 26/06/12
- Days to filing
- 0 days
Sold 67.2% of holdings
- Share of holding sold
- 67.2%
ARS Pharmaceuticals trades, last 26 weeks
What else happened in ARS Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 05/13~07/12Eric Karas's recent trades
- Eric Karas
Planned saleARS Pharmaceuticals
Planned saleARS Pharmaceuticals
SPRY
$431.6K
100,000 sh
$431.6K
Filed 09/30
Traded 09/30
- Eric Karas
Planned saleARS Pharmaceuticals
Planned saleARS Pharmaceuticals
SPRY
$69.8K
14,064 sh
$69.8K
Filed 09/11
Traded 09/11
- Eric Karas
Planned sale10b5-1 planARS Pharmaceuticals
Planned sale10b5-1 planARS Pharmaceuticals
SPRY
$250K
25,000 sh
$250K
Filed 06/12
Traded 06/12
- Eric Karas
Sell10b5-1 planARS Pharmaceuticals
Sell10b5-1 planARS Pharmaceuticals
SPRY
$254.9K
15,000 sh
$254.9K
Filed 25/07/03
Traded 25/07/01
- Eric Karas
Planned sale10b5-1 planARS Pharmaceuticals
Planned sale10b5-1 planARS Pharmaceuticals
SPRY
$254.9K
15,000 sh
$254.9K
Filed 25/07/01
Traded 25/07/01